Internal Medicine, Medical Oncology · San Antonio, TX
NPI
1285836098
Since 2007
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
5206 Research Dr
San Antonio, TX, 78240
Phone (210) 595-5300
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.1M
136,775 services
Medicare patients, 2024
856
Average age 73
Drug cost, 2024
$4.7M
2,680 prescriptions
Company payments, 2025
$216
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Suneetha Challagundla was code J1453 (injection, fosaprepitant, 1 mg), 9,750 times for 29 patients. In total Suneetha Challagundla billed 136,775 services in 184 codes, and Medicare paid $2.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1453 Injection, fosaprepitant, 1 mg | Office | 9,750 | 29 | $0.11 | $1,081 |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 7,650 | 11 | $0.24 | $1,840 |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 4,669 | 47 | $0.10 | $458 |
| J0897 Injection, denosumab, 1 mg | Office | 3,060 | 12 | $20.73 | $63K |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 2,840 | 23 | $34.60 | $98K |
| 88185 Surgical Pathology Examination | Office | 2,246 | 88 | $17.41 | $39K |
| 36415 Venipuncture Blood Collection | Office | 2,032 | 505 | $8.65 | $18K |
| 80053 Clinical Chemistry | Office | 1,986 | 520 | $10.28 | $20K |
| 85025 Blood Count | Office | 1,972 | 522 | $7.55 | $15K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,338 | 55 | $0.09 | $115 |
| 99214 Office E&M - Established | Office | 1,222 | 496 | $88.32 | $108K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 901 | 37 | $0.71 | $642 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 820 | 23 | $0.24 | $196 |
| 82784 Immunoassay | Office | 735 | 120 | $9.00 | $6,614 |
| 83615 Clinical Chemistry | Office | 597 | 319 | $5.87 | $3,504 |
By year: 2022 $2.3M for 165,648 services; 2023 $2.0M for 141,341 services; 2024 $2.1M for 136,775 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88185 Surgical Pathology Examination | 2,246 | 88 | $17.41 | $39K |
| 36415 Venipuncture Blood Collection | 2,032 | 505 | $8.65 | $18K |
| 80053 Clinical Chemistry | 1,986 | 520 | $10.28 | $20K |
| 85025 Blood Count | 1,972 | 522 | $7.55 | $15K |
| 82784 Immunoassay | 735 | 120 | $9.00 | $6,614 |
| 83615 Clinical Chemistry | 597 | 319 | $5.87 | $3,504 |
| 82728 Clinical Chemistry | 495 | 265 | $13.20 | $6,534 |
| 83550 Clinical Chemistry | 494 | 265 | $8.47 | $4,183 |
| 83540 Clinical Chemistry | 494 | 265 | $6.26 | $3,095 |
| 83521 Immunoassay | 342 | 92 | $16.84 | $5,758 |
Medicare prescription drug claims, 2024
In 2024, the drug Suneetha Challagundla prescribed most often to Medicare patients was Eliquis (Apixaban), with 267 prescriptions and refills. In total Suneetha Challagundla wrote 2,680 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 267 | 389 | 75 | $218K |
| Letrozole Generic | 258 | 452 | 48 | $3,939 |
| Acyclovir Generic | 144 | 180 | 27 | $1,165 |
| Gabapentin Generic | 117 | 121 | 25 | $805 |
| Prednisone Generic | 95 | 99 | 27 | $409 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 86 | 110 | 19 | $324 |
| Xarelto Rivaroxaban | 85 | 127 | 19 | $69K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 82 | 82 | 24 | $2,854 |
| Allopurinol Generic | 82 | 118 | 18 | $374 |
| Hydroxyurea Generic | 72 | 133 | 18 | $1,251 |
| Zarxio Filgrastim-Sndz | 68 | 68 | 12 | $203K |
| Revlimid Lenalidomide | 66 | 66 | Under 11 | $1.1M |
| Potassium Chloride Generic | 55 | 61 | 22 | $715 |
| Furosemide Generic | 49 | 65 | 17 | $138 |
| Dexamethasone Generic | 44 | 59 | 17 | $984 |
Brand drugs: 790 claims; generic drugs: 1,890 claims; opioid claims: 146.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Suneetha Challagundla $216 ($216 in general payments such as food, travel and fees) from 5 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $124.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.